When GlaxoSmithKline (GSK) exited Nigeria in late 2023, it left a major gap in the country’s pharmaceutical supply chain. One
read more Mecure investors ride antibiotic boom after GSK’s exit
Share
When GlaxoSmithKline (GSK) exited Nigeria in late 2023, it left a major gap in the country’s pharmaceutical supply chain. One
read more Mecure investors ride antibiotic boom after GSK’s exit
Read more